Cargando…

Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation

BACKGROUND: Lipotoxicity is a key feature of the pathogenesis of diabetic kidney disease, and is attributed to excessive lipid accumulation (hyperlipidemia). Increasing evidence suggests that fibroblast growth factor (FGF)21 has a crucial role in lipid metabolism under diabetic conditions. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chi, Shao, Minglong, Yang, Hong, Chen, Liangmiao, Yu, Lechu, Cong, Weitao, Tian, Haishan, Zhang, Fangfang, Cheng, Peng, Jin, Litai, Tan, Yi, Li, Xiaokun, Cai, Lu, Lu, Xuemian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857822/ https://www.ncbi.nlm.nih.gov/pubmed/24349242 http://dx.doi.org/10.1371/journal.pone.0082275

Ejemplares similares

Multiple Low-Dose Radiation Prevents Type 2 Diabetes-Induced Renal Damage through Attenuation of Dyslipidemia and Insulin Resistance and Subsequent Renal Inflammation and Oxidative Stress
por: Shao, Minglong, et al.
Publicado: (2014)

Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China
por: Yang, Hong, et al.
Publicado: (2014)

Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
por: Lin, Sundong, et al.
Publicado: (2020)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
por: Yang, Hong, et al.
Publicado: (2018)

The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage
por: Zhang, Chi, et al.
Publicado: (2013)

Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
por: Weng, Wenya, et al.
Publicado: (2020)

Insignificant Effect of Isolated Hypothyroxinemia on Pregnancy Outcomes During the First and Second Trimester of Pregnancy
por: Chen, Liangmiao, et al.
Publicado: (2020)

Suppression of Cutibacterium acnes-Mediated Inflammatory Reactions by Fibroblast Growth Factor 21 in Skin
por: Yu, Ying, et al.
Publicado: (2022)

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
por: Kohara, Marina, et al.
Publicado: (2017)

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice
por: Yan, Xiaoqing, et al.
Publicado: (2015)

Clinical Significance of miR-21-5p in Predicting Occurrence and Progression of Uremic Vascular Calcification in Patients with End-Stage Renal Disease
por: Wu, Rong, et al.
Publicado: (2022)

Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model
por: Zhang, Chi, et al.
Publicado: (2012)

Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway
por: Yu, Lechu, et al.
Publicado: (2021)

BL153 Partially Prevents High-Fat Diet Induced Liver Damage Probably via Inhibition of Lipid Accumulation, Inflammation, and Oxidative Stress
por: Wang, Jian, et al.
Publicado: (2014)

Maternal thyroid peroxidase antibody positivity and its association with incidence of low birth weight in infants
por: Chen, Liangmiao, et al.
Publicado: (2023)

EP(1) receptor antagonism mitigates early and late stage renal fibrosis
por: Kresse, Jean‐Claude, et al.
Publicado: (2022)

Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
por: Lin, Zhuofeng, et al.
Publicado: (2011)

Multimodality MRI Findings in Patients with End-Stage Renal Disease
por: Chen, Hui Juan, et al.
Publicado: (2015)

Adiponectin Gene Polymorphism rs2241766 T/G Is Associated with Response to Pioglitazone Treatment in Type 2 Diabetic Patients from Southern China
por: Yang, Hong, et al.
Publicado: (2014)

Feedback Activation of Basic Fibroblast Growth Factor Signaling via the Wnt/β-Catenin Pathway in Skin Fibroblasts
por: Wang, Xu, et al.
Publicado: (2017)

EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation
por: Fang, Qilu, et al.
Publicado: (2016)

Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
por: Abudiab, Muaz M., et al.
Publicado: (2014)

Syncope as the Initial Manifestation of a Late-Stage Renal Cell Carcinoma With Metastasis to the Brain
por: Ying, Grace W, et al.
Publicado: (2021)

Late Diagnosis of Primary Hyperoxaluria in an Adult Patient With End-Stage Renal Disease and Bicytopenia
por: Miry, Achref, et al.
Publicado: (2023)

Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
por: Lønning, Kjersti, et al.
Publicado: (2016)

Primary Renal Lymphoma Presenting as End-Stage Renal Disease
por: Butani, Lavjay, et al.
Publicado: (2017)

Hyperlipidemia and hyper glycaemia in Breast Cancer Patients is related to disease stage
por: Raza, Uzma, et al.
Publicado: (2018)

Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions
por: Baer, Gernot, et al.
Publicado: (2010)

Functional characterization of late outgrowth endothelial progenitor cells in patients with end-stage renal failure
por: Zhao, Jing, et al.
Publicado: (2014)

Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer
por: Bhalla, Sherry, et al.
Publicado: (2017)

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016)

The role of FGF21 in type 1 diabetes and its complications
por: Zhang, Jian, et al.
Publicado: (2018)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease
por: Wang, Yinghui, et al.
Publicado: (2022)

Effect of Thymoquinone on Renal Damage Induced by Hyperlipidemia in LDL Receptor-Deficient (LDL-R(−)/(−)) Mice
por: Li, Wanjing, et al.
Publicado: (2022)

End-Stage Renal Disease and Renal Replacement Therapy in older Patients
por: Smyth, Andrew
Publicado: (2012)

Renal replacement therapy in Latin American end-stage renal disease
por: Rosa-Diez, Guillermo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d9a33vkdn85d2h27vetj5got79